Cargando…

A Depressive Endophenotype of Mild Cognitive Impairment and Alzheimer’s Disease

BACKGROUND: Alzheimer’s disease (AD) is a devastating public health problem that affects over 5.4 million Americans. Depression increases the risk of Mild Cognitive Impairment (MCI) and AD. By understanding the influence of depression on cognition, the potential exists to identify subgroups of depre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Leigh A., Hall, James R., O’Bryant, Sid E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708919/ https://www.ncbi.nlm.nih.gov/pubmed/23874786 http://dx.doi.org/10.1371/journal.pone.0068848

Ejemplares similares

Depressive Symptom Clusters and Neuropsychological Performance in Mild Alzheimer's and Cognitively Normal Elderly
por: Hall, James R., et al.
Publicado: (2011)

Cardiovascular Risk Factors, Cognitive Dysfunction, and Mild Cognitive Impairment
por: Vintimilla, Raul, et al.
Publicado: (2020)

Depression is differentially related to cognitive and biomarker outcomes among Mexican Americans
por: O’Bryant, Sid E., et al.
Publicado: (2022)

The Link between Potassium and Mild Cognitive Impairment in Mexican-Americans
por: Vintimilla, Raul M., et al.
Publicado: (2018)

Proteomic profiles of incident mild cognitive impairment and Alzheimer's disease among adults with Down syndrome
por: O'Bryant, Sid E., et al.
Publicado: (2020)

Proteomic profiles of prevalent mild cognitive impairment and Alzheimer's disease among adults with Down syndrome
por: Petersen, Melissa, et al.
Publicado: (2020)

The relationship of CRP and cognition in cognitively normal older Mexican Americans: A cross-sectional study of the HABLE cohort
por: Vintimilla, Raul, et al.
Publicado: (2019)

Accelerating Hyperparameter Tuning in Machine Learning for Alzheimer’s Disease With High Performance Computing
por: Zhang, Fan, et al.
Publicado: (2021)

Combination of Serum and Plasma Biomarkers Could Improve Prediction Performance for Alzheimer’s Disease
por: Zhang, Fan, et al.
Publicado: (2022)

Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults
por: Hall, James R., et al.
Publicado: (2021)

Hyperparameter Tuning with High Performance Computing Machine Learning for Imbalanced Alzheimer’s Disease Data
por: Zhang, Fan, et al.
Publicado: (2022)

The Link between Cognitive Measures and ADLs and IADL Functioning in Mild Alzheimer's: What Has Gender Got to Do with It?
por: Hall, James R., et al.
Publicado: (2011)

Characterizing Plasma Biomarkers of Alzheimer's in a Diverse Community-Based Cohort: A Cross-Sectional Study of the HAB-HD Cohort
por: Hall, James R., et al.
Publicado: (2022)

Cardiovascular Risk Factors and Cognitive Performance in Cognitively Normal Non-Hispanic Whites and Mexican Americans From the HABS-HD Cohort
por: Vintimilla, Raul, et al.
Publicado: (2022)

Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes
por: Espinosa, Ana, et al.
Publicado: (2018)

Subjective cognitive complaints and cardiovascular risk factors in older Mexican Americans: A cross-sectional study.
por: Vintimilla, Raul, et al.
Publicado: (2022)

A Precision Medicine Approach to Treating Alzheimer’s Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials
por: O’Bryant, Sid E., et al.
Publicado: (2021)

Introduction to special issue on Advances in blood-based biomarkers of Alzheimer's disease
por: O'Bryant, Sid E.
Publicado: (2016)

Molecular markers of neuropsychological functioning and Alzheimer's disease
por: Edwards, Melissa, et al.
Publicado: (2015)

Factor structure and measurement invariance of a neuropsychological test battery designed for assessment of cognitive functioning in older Mexican Americans
por: Gavett, Brandon E., et al.
Publicado: (2018)

Association Between Cognitive Impairment and Chronic Kidney Disease in Mexican Americans
por: Szerlip, Harold M., et al.
Publicado: (2015)

A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community‐dwelling Mexican Americans and non‐Hispanic Whites: A method for increasing representation of diverse populations in clinical research
por: O'Bryant, Sid E., et al.
Publicado: (2021)

Depression, inflammation, and memory loss among Mexican Americans: analysis of the HABLE cohort
por: Johnson, Leigh A., et al.
Publicado: (2017)

APOEε4 Genotype Is Related to Brain Amyloid Among Mexican Americans in the HABS-HD Study
por: O'Bryant, Sid E., et al.
Publicado: (2022)

Circulating mitochondrial DNA: New indices of type 2 diabetes-related cognitive impairment in Mexican Americans
por: Silzer, Talisa, et al.
Publicado: (2019)

A blood screening test for Alzheimer's disease
por: O'Bryant, Sid E., et al.
Publicado: (2016)

MRI biomarkers of small vessel disease and cognition: A cross‐sectional study of a cognitively normal Mexican American cohort
por: Vintimilla, Raul, et al.
Publicado: (2021)

Parkinson’s Disease Blood Test for Primary Care
por: O’Bryant, Sid E., et al.
Publicado: (2022)

Application of Structural Retinal Biomarkers to Detect Cognitive Impairment in a Primary Care Setting
por: Mozdbar, Sima, et al.
Publicado: (2022)

Prevalence of Alzheimer’s Pathologic Endophenotypes in Asymptomatic and Mildly Impaired First-Degree Relatives
por: Lampert, Erika J., et al.
Publicado: (2013)

Total testosterone and neuropsychiatric symptoms in elderly men with Alzheimer’s disease
por: Hall, James R, et al.
Publicado: (2015)

Association of Area Deprivation Index and hypertension, diabetes, dyslipidemia, and Obesity: A Cross-Sectional Study of the HABS-HD Cohort
por: Vintimilla, Raul, et al.
Publicado: (2023)

Factores de riesgo cardiovascular en Estados Unidos y México: comparación de los estudios HABLE y ENASEM
por: Vintimilla, Raúl, et al.
Publicado: (2020)

Association of cardiovascular risk factors and blood biomarkers with cognition: The HABS‐HD study
por: Jiang, Xiaqing, et al.
Publicado: (2023)

Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study
por: O'Bryant, Sid E., et al.
Publicado: (2019)

Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study
por: Petersen, Melissa E., et al.
Publicado: (2020)

Awareness, apathy, and depression in Alzheimer's disease and mild cognitive impairment
por: Jacus, Jean‐Pierre
Publicado: (2017)

Inflammatory Biomarkers, Depressive Symptoms and Falls among the Elderly in Panama
por: Britton, Gabrielle B., et al.
Publicado: (2018)

Serum Granulocyte Colony-Stimulating Factor and Alzheimer's Disease
por: Barber, Robert C., et al.
Publicado: (2012)

Cognitive dysfunction and the 25‐item National Eye Institute Visual Function Questionnaire
por: Mozdbar, Sima, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m96b3ut3iluarmcqtvfdo86jf3